Circulating perivascular dilatory neuropeptides in hypertension
- PMID: 2483731
- DOI: 10.1097/00004872-198900076-00093
Circulating perivascular dilatory neuropeptides in hypertension
Abstract
Little is known about perivascular neuropeptides in hypertension in man. In this study we investigated the circulating levels of calcitonin gene-related peptide (CGRP)-, substance P- and vasoactive intestinal peptide-like immunoreactivity in 30 patients with severe hypertension before and after treatment for high blood pressure. Circulating levels of CGRP- and substance P-like immunoreactivity in the hypertensives were significantly different from the corresponding levels in 31 age- and sex-matched normotensive subjects. After normalization of blood pressure the mean levels of CGRP- and substance P-like immunoreactivity did not differ between the two groups. The levels of vasoactive intestinal peptide-like immunoreactivity remained unchanged. These observations suggest that vascular afferent nerves play a part in the maintenance of hypertension.
Similar articles
-
Reduced levels of calcitonin gene-related peptide (CGRP) but not substance P during and after treatment of severe hypertension in man.J Hum Hypertens. 1989 Aug;3(4):267-70. J Hum Hypertens. 1989. PMID: 2477545
-
Sensory nerve terminal activity in severe hypertension as reflected by circulating calcitonin gene-related peptide (CGRP) and substance P.Blood Press. 1992 Dec;1(4):223-9. doi: 10.3109/08037059209077667. Blood Press. 1992. PMID: 1285370
-
Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease.Br J Rheumatol. 1993 Jan;32(1):31-5. doi: 10.1093/rheumatology/32.1.31. Br J Rheumatol. 1993. PMID: 7678534
-
Innervation and effects of dilatory neuropeptides on cerebral vessels. New aspects.Blood Vessels. 1991;28(1-3):35-45. doi: 10.1159/000158841. Blood Vessels. 1991. PMID: 2001478 Review.
-
Normal serum levels of calcitonin gene-related peptide (CGRP) in mild to moderate essential hypertension.Am J Hypertens. 1991 Jul;4(7 Pt 1):565-9. doi: 10.1093/ajh/4.7.565. Am J Hypertens. 1991. PMID: 1873010 Review.
Cited by
-
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study.Neurol Sci. 2024 Apr;45(4):1661-1668. doi: 10.1007/s10072-023-07167-z. Epub 2023 Nov 6. Neurol Sci. 2024. PMID: 37926748
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials